NEVRO CORP Insider Trading for November 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEVRO CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEVRO CORP for November 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26 2019 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 63.23 | 12,000 | 758,760 | 20,500 | |
| Nov 26 2019 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 110.39 | 12,000 | 1,324,714 | 53,490 | 65.5 K to 53.5 K (-18.32 %) |
| Nov 26 2019 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 63.23 | 12,000 | 758,760 | 65,490 | 53.5 K to 65.5 K (+22.43 %) |
| Nov 26 2019 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality | Sell | S | 110.00 | 1,000 | 110,000 | 24,073 | 25.1 K to 24.1 K (-3.99 %) |
| Nov 13 2019 | NVRO | NEVRO CORP | McCormick Shawn | Director | Sell | S | 104.35 | 800 | 83,480 | 7,416 | 8.2 K to 7.4 K (-9.74 %) |
| Nov 13 2019 | NVRO | NEVRO CORP | McCormick Shawn | Director | Sell | S | 104.35 | 800 | 83,480 | 7,416 | 8.2 K to 7.4 K (-9.74 %) |
| Nov 13 2019 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 104.68 | 4,610 | 482,572 | 429,519 | 434.1 K to 429.5 K (-1.06 %) |
| Nov 13 2019 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 104.68 | 4,610 | 482,572 | 429,519 | 434.1 K to 429.5 K (-1.06 %) |
| Nov 13 2019 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 103.72 | 37,116 | 3,849,779 | 434,129 | 471.2 K to 434.1 K (-7.88 %) |
| Nov 13 2019 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 103.72 | 37,116 | 3,849,779 | 434,129 | 471.2 K to 434.1 K (-7.88 %) |
| Nov 13 2019 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 103.07 | 8,274 | 852,812 | 471,245 | 479.5 K to 471.2 K (-1.73 %) |
| Nov 13 2019 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 103.07 | 8,274 | 852,812 | 471,245 | 479.5 K to 471.2 K (-1.73 %) |
| Nov 13 2019 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 63.23 | 12,000 | 758,760 | 32,500 | |
| Nov 13 2019 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 63.23 | 12,000 | 758,760 | 32,500 | |
| Nov 13 2019 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 18.00 | 6,522 | 117,396 | 14,941 | |
| Nov 13 2019 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 18.00 | 6,522 | 117,396 | 14,941 | |
| Nov 13 2019 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 104.75 | 1,175 | 123,075 | 53,490 | 54.7 K to 53.5 K (-2.15 %) |
| Nov 13 2019 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 104.75 | 1,175 | 123,075 | 53,490 | 54.7 K to 53.5 K (-2.15 %) |
| Nov 13 2019 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 103.85 | 10,345 | 1,074,287 | 54,665 | 65 K to 54.7 K (-15.91 %) |
| Nov 13 2019 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 103.85 | 10,345 | 1,074,287 | 54,665 | 65 K to 54.7 K (-15.91 %) |
| Nov 13 2019 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 103.31 | 7,002 | 723,369 | 65,010 | 72 K to 65 K (-9.72 %) |
| Nov 13 2019 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 103.31 | 7,002 | 723,369 | 65,010 | 72 K to 65 K (-9.72 %) |
| Nov 13 2019 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 63.23 | 12,000 | 758,760 | 72,012 | 60 K to 72 K (+20.00 %) |
| Nov 13 2019 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 63.23 | 12,000 | 758,760 | 72,012 | 60 K to 72 K (+20.00 %) |
| Nov 13 2019 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 18.00 | 6,522 | 117,396 | 60,012 | 53.5 K to 60 K (+12.19 %) |
| Nov 13 2019 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 18.00 | 6,522 | 117,396 | 60,012 | 53.5 K to 60 K (+12.19 %) |
| Nov 08 2019 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality | Sell | S | 100.00 | 1,000 | 100,000 | 25,073 | 26.1 K to 25.1 K (-3.84 %) |
| Nov 05 2019 | NVRO | NEVRO CORP | Schmitz Patrick | Vice President, Ope ... | Payment of Exercise | F | 86.63 | 1,562 | 135,316 | 18,658 | 20.2 K to 18.7 K (-7.73 %) |
| Nov 05 2019 | NVRO | NEVRO CORP | Rashid Kashif | General Counsel | Payment of Exercise | F | 86.63 | 1,404 | 121,629 | 28,203 | 29.6 K to 28.2 K (-4.74 %) |
| Nov 05 2019 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Payment of Exercise | F | 86.63 | 1,713 | 148,397 | 53,490 | 55.2 K to 53.5 K (-3.10 %) |
| Nov 05 2019 | NVRO | NEVRO CORP | Christoforou Christofer | VP, Research & Deve ... | Payment of Exercise | F | 86.63 | 1,252 | 108,461 | 19,570 | 20.8 K to 19.6 K (-6.01 %) |
| Nov 05 2019 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality | Payment of Exercise | F | 86.63 | 1,562 | 135,316 | 26,073 | 27.6 K to 26.1 K (-5.65 %) |